P
Philippe Metellus
Researcher at Aix-Marseille University
Publications - 186
Citations - 6330
Philippe Metellus is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 39, co-authored 178 publications receiving 5460 citations. Previous affiliations of Philippe Metellus include University of the Mediterranean & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
Riccardo Soffietti,Ufuk Abacioglu,Brigitta G. Baumert,Stephanie E. Combs,Sara Kinhult,Johan M. Kros,Christine Marosi,Philippe Metellus,Alexander Radbruch,Salvador Villà Freixa,Michael Brada,Carmine M. Carapella,Matthias Preusser,Emilie Le Rhun,Roberta Rudà,Joerg C. Tonn,Damien C. Weber,Michael Weller +17 more
TL;DR: These guidelines are presented, which provide a consensus review of evidence and recommendations for diagnosis by neuroimaging and neuropathology, staging, prognostic factors, and different treatment options for patients with brain metastases from solid tumors.
Journal Article
Recent Trends in Epidemiology of Brain Metastases: An Overview
Emeline Tabouret,Olivier Chinot,Philippe Metellus,Agnès Tallet,Patrice Viens,Anthony Gonçalves +5 more
TL;DR: Progress in the development of systemic treatments, together with the rationalized use of surgical resection, radiosurgery and whole-brain radiotherapy, have led to an increase in the number of long-term survivors and in median survival, which should allow further improvements in prognosis of this devastating disease.
Journal ArticleDOI
Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia
Jean Régis,Philippe Metellus,Motohiro Hayashi,Philippe Roussel,Anne Donnet,Françoise Bille-Turc +5 more
TL;DR: Radiosurgery is a safe and effective alternative treatment for trigeminal neuralgia and is associated with a particularly low rate of hypesthesia.
Journal ArticleDOI
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.
Philippe Metellus,Béma Coulibaly,Carole Colin,Carole Colin,André Maues De Paula,Alexandre Vasiljevic,David Taïeb,Anne Barlier,Anne Barlier,Blandine Boisselier,Blandine Boisselier,Blandine Boisselier,Karima Mokhtari,Karima Mokhtari,Karima Mokhtari,Xiao Wei Wang,Xiao Wei Wang,Xiao Wei Wang,Anderson Loundou,F. Chapon,Sandrine Pineau,L'Houcine Ouafik,L'Houcine Ouafik,Olivier Chinot,Olivier Chinot,Dominique Figarella-Branger,Dominique Figarella-Branger +26 more
TL;DR: The absence of IDH mutations in LGGs identifies a novel entity of L GGs with distinctive location, infiltrative behavior, specific molecular alterations, and dismal outcome that could significantly modify the LGG classification and may represent a new tool to guide patient-tailored therapy.
Journal ArticleDOI
Correlation Between O6-Methylguanine-DNA Methyltransferase and Survival in Inoperable Newly Diagnosed Glioblastoma Patients Treated With Neoadjuvant Temozolomide
Olivier Chinot,Maryline Barrie,Stéphane Fuentes,N. Eudes,Sophie Lancelot,Philippe Metellus,Xavier Muracciole,Diane Braguer,L'Houcine Ouafik,Pierre-Marie Martin,Henry Dufour,Dominique Figarella-Branger +11 more
TL;DR: This dose-dense temozolomide regimen resulted in modest antitumor activity with an acceptable safety profile in the neoadjuvant setting, and expression of MGMT correlated with response to temozalomide.